The Research Progress of Direct Thrombin Inhibitors

Roth, G.A.; Johnson, C.; Abajobir, A.; Abd-Allah, F.; Abera, S.F.; Abyu, G.; Ahmed, M.; Aksut, B.; Alam, T.; Alam, K.; Alla, F.; Alvis-Guzman, N.; Amrock, S.; Ansari, H.; Ärnlöv, J.; Asayesh, H.; Atey, T.M.; Avila-Burgos, L.; Awasthi, A.; Banerjee, A.; Barac, A.; Bärnighausen, T.; Barregard, L.; Bedi, N.; Belay Ketema, E.; Bennett, D.; Berhe, G.; Bhutta, Z.; Bitew, S.; Carapetis, J.; Carrero, J.J.; Malta, D.C.; Castañeda-Orjuela, C.A.; Castillo-Rivas, J.; Catalá-López, F.; Choi, J.Y.; Christensen, H.; Cirillo, M.; Cooper, L., Jr; Criqui, M.; Cundiff, D.; Damasceno, A.; Dandona, L.; Dandona, R.; Davletov, K.; Dharmaratne, S.; Dorairaj, P.; Dubey, M.; Ehrenkranz, R.; El Sayed Zaki, M.; Faraon, E.J.A.; Esteghamati, A.; Farid, T.; Farvid, M.; Feigin, V.; Ding, E.L.; Fowkes, G.; Gebrehiwot, T.; Gillum, R.; Gold, A.; Gona, P.; Gupta, R.; Habtewold, T.D.; Hafezi-Nejad, N.; Hailu, T.; Hailu, G.B.; Hankey, G.; Hassen, H.Y.; Abate, K.H.; Havmoeller, R.; Hay, S.I.; Horino, M.; Hotez, P.J.; Jacobsen, K.; James, S.; Javanbakht, M.; Jeemon, P.; John, D.; Jonas, J.; Kalkonde, Y.; Karimkhani, C.; Kasaeian, A.; Khader, Y.; Khan, A.; Khang, Y.H.; Khera, S.; Khoja, A.T.; Khubchandani, J.; Kim, D.; Kolte, D.; Kosen, S.; Krohn, K.J.; Kumar, G.A.; Kwan, G.F.; Lal, D.K.; Larsson, A.; Linn, S.; Lopez, A.; Lotufo, P.A.; El Razek, H.M.A.; Malekzadeh, R.; Mazidi, M.; Meier, T.; Meles, K.G.; Mensah, G.; Meretoja, A.; Mezgebe, H.; Miller, T.; Mirrakhimov, E.; Mohammed, S.; Moran, A.E.; Musa, K.I.; Narula, J.; Neal, B.; Ngalesoni, F.; Nguyen, G.; Obermeyer, C.M.; Owolabi, M.; Patton, G.; Pedro, J.; Qato, D.; Qorbani, M.; Rahimi, K.; Rai, R.K.; Rawaf, S.; Ribeiro, A.; Safiri, S.; Salomon, J.A.; Santos, I.; Santric Milicevic, M.; Sartorius, B.; Schutte, A.; Sepanlou, S.; Shaikh, M.A.; Shin, M.J.; Shishehbor, M.; Shore, H.; Silva, D.A.S.; Sobngwi, E.; Stranges, S.; Swaminathan, S.; Tabarés-Seisdedos, R.; Tadele Atnafu, N.; Tesfay, F.; Thakur, J.S.; Thrift, A.; Topor-Madry, R.; Truelsen, T.; Tyrovolas, S.; Ukwaja, K.N.; Uthman, O.; Vasankari, T.; Vlassov, V.; Vollset, S.E.; Wakayo, T.; Watkins, D.; Weintraub, R.; Werdecker, A.; Westerman, R.; Wiysonge, C.S.; Wolfe, C.; Workicho, A.; Xu, G.; Yano, Y.; Yip, P.; Yonemoto, N.; Younis, M.; Yu, C.; Vos, T.; Naghavi, M.; Murray, C. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J. Am. Coll. Cardiol., 2017, 70(1), 1-25.
[http://dx.doi.org/10.1016/j.jacc.2017.04.052] [PMID: 28527533]

Coutinho, J.M.; Zuurbier, S.M.; Aramideh, M.; Stam, J. The incidence of cerebral venous thrombosis: A cross-sectional study. Stroke, 2012, 43(12), 3373-3377.
[http://dx.doi.org/10.1161/STROKEAHA.112.671453] [PMID: 22996960]

DeVon, H.A.; Ryan, C.J.; Ochs, A.L.; Shapiro, M. Symptoms across the continuum of acute coronary syndromes: Differences between women and men. Am. J. Crit. Care, 2008, 17(1), 14-24.
[PMID: 18158385]

Alsén, P.; Brink, E.; Brändström, Y.; Karlson, B.W.; Persson, L.O. Fatigue after myocardial infarction: relationships with indices of emotional distress, and sociodemographic and clinical variables. Int. J. Nurs. Pract., 2010, 16(4), 326-334.
[http://dx.doi.org/10.1111/j.1440-172X.2010.01848.x] [PMID: 20649663]

Frazier, L.; Yu, E.; Sanner, J.; Liu, F.; Udtha, M.; Cron, S.; Coulter, S.; Bogaev, R.C. Gender differences in self-reported symptoms of depression among patients with acute coronary syndrome. Nurs. Res. Pract., 2012.2012109251
[http://dx.doi.org/10.1155/2012/109251] [PMID: 22567222]

Royle, N.J.; Irwin, D.M.; Koschinsky, M.L.; MacGillivray, R.T.; Hamerton, J.L. Human genes encoding prothrombin and ceruloplasmin map to 11p11-q12 and 3q21-24, respectively. Somat. Cell Mol. Genet., 1987, 13(3), 285-292.
[http://dx.doi.org/10.1007/BF01535211] [PMID: 3474786]

Davie, E.W.; Kulman, J.D. An overview of the structure and function of thrombin. Semin. Thromb. Hemost., 2006, 32, 3-15.
[http://dx.doi.org/10.1055/s-2006-939550]

Nar, H. The role of structural information in the discovery of direct thrombin and factor Xa inhibitors. Trends Pharmacol. Sci., 2012, 33(5), 279-288.
[http://dx.doi.org/10.1016/j.tips.2012.03.004] [PMID: 22503439]

Hirsh, J.; O’Donnell, M.; Weitz, J.I. New anticoagulants. Blood, 2005, 105(2), 453-463.
[http://dx.doi.org/10.1182/blood-2003-12-4195] [PMID: 15191946]

Mao, S.J.; Yates, M.T.; Owen, T.J.; Krstenansky, J.L. Interaction of hirudin with thrombin: Identification of a minimal binding domain of hirudin that inhibits clotting activity. Biochemistry, 1988, 27(21), 8170-8173.
[http://dx.doi.org/10.1021/bi00421a027] [PMID: 3233202]

Seybert, A.L.; Coons, J.C.; Zerumsky, K. Treatment of heparin-induced thrombocytopenia: Is there a role for bivalirudin? Pharmacotherapy, 2006, 26(2), 229-241.
[http://dx.doi.org/10.1592/phco.26.2.229] [PMID: 16466327]

O’Dell, K.M.; Igawa, D.; Hsin, J. New oral anticoagulants for atrial fibrillation: A review of clinical trials. Clin. Ther., 2012, 34(4), 894-901.
[http://dx.doi.org/10.1016/j.clinthera.2012.01.019] [PMID: 22417716]

Di Nisio, M.; Middeldorp, S.; Büller, H.R. Direct thrombin inhibitors. N. Engl. J. Med., 2005, 353(10), 1028-1040.
[http://dx.doi.org/10.1056/NEJMra044440] [PMID: 16148288]

Graetz, T.J.; Tellor, B.R.; Smith, J.R.; Avidan, M.S. Desirudin: A review of the pharmacology and clinical application for the prevention of deep vein thrombosis. Expert Rev. Cardiovasc. Ther., 2011, 9(9), 1101-1109.
[http://dx.doi.org/10.1586/erc.11.131] [PMID: 21932952]

Baker, D.D.; Chu, M.; Oza, U.; Rajgarhia, V. The value of natural products to future pharmaceutical discovery. Nat. Prod. Rep., 2007, 24(6), 1225-1244.
[http://dx.doi.org/10.1039/b602241n] [PMID: 18033577]

Cragg, G.M.; Newman, D.J. Natural products: A continuing source of novel drug leads. Biochimica et Biophysica Acta (BBA) -. General Subjects, 2013, 1830(6), 3670-3695.
[http://dx.doi.org/10.1016/j.bbagen.2013.02.008]

Mishra, B.B.; Tiwari, V.K. Natural products: An evolving role in future drug discovery. Eur. J. Med. Chem., 2011, 46(10), 4769-4807.
[http://dx.doi.org/10.1016/j.ejmech.2011.07.057] [PMID: 21889825]

Liu, L.; Ma, H.; Yang, N.; Tang, Y.; Guo, J.; Tao, W.; Duan, J. A series of natural flavonoids as thrombin inhibitors: Structureactivity relationships. Thromb. Res., 2010, 126(5), e365-e378.
[http://dx.doi.org/10.1016/j.thromres.2010.08.006] [PMID: 20828797]

Shi, Z.H.; Li, N.G.; Tang, Y.P.; Wei-Li, Y.P.; Lian-Yin, Y.P.; Yang, J.P.; Hao-Tang, Y.P.; Duan, J.A. Metabolism-based synthesis, biologic evaluation and SARs analysis of O-methylated analogs of quercetin as thrombin inhibitors. Eur. J. Med. Chem., 2012, 54(11), 210-222.
[http://dx.doi.org/10.1016/j.ejmech.2012.04.044] [PMID: 22647223]

Li, N-G.; Song, S-L.; Shen, M-Z.; Tang, Y-P.; Shi, Z-H.; Tang, H.; Shi, Q-P.; Fu, Y-F.; Duan, J-A. Mannich bases of scutellarein as thrombin-inhibitors: Design, synthesis, biological activity and solubility. Bioorg. Med. Chem., 2012, 20(24), 6919-6923.
[http://dx.doi.org/10.1016/j.bmc.2012.10.015] [PMID: 23131413]

Rodrigues, C.F.B.; Gaeta, H.H.; Belchor, M.N.; Ferreira, M.J.P.; Pinho, M.V.T. Toyama, Dde.O.; Toyama, M.H. Evaluation of potential thrombin inhibitors from the white mangrove (Laguncularia racemosa (L.) CF Gaertn.). Mar. Drugs, 2015, 13(7), 4505-4519.
[http://dx.doi.org/10.3390/md13074505] [PMID: 26197325]

Lu, J.; Song, H-P.; Li, P.; Zhou, P.; Dong, X.; Chen, J. Screening of direct thrombin inhibitors from Radix Salviae Miltiorrhizae by a peak fractionation approach. J. Pharm. Biomed. Anal., 2015, 109, 85-90.
[http://dx.doi.org/10.1016/j.jpba.2015.02.020] [PMID: 25819728]

Wang, X.; Zhang, Y.; Yang, Y.; Wu, X.; Fan, H.; Qiao, Y. Identification of berberine as a direct thrombin inhibitor from traditional Chinese medicine through structural, functional and binding studies. Sci. Rep., 2017, 7, 44040.
[http://dx.doi.org/10.1038/srep44040] [PMID: 28276481]

Waxman, L.; Smith, D.E.; Arcuri, K.E.; Vlasuk, G.P. Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. Science, 1990, 248(4955), 593-596.
[http://dx.doi.org/10.1126/science.2333510] [PMID: 2333510]

Iyer, J.K.; Koh, C.Y.; Kazimirova, M.; Roller, L.; Jobichen, C.; Swaminathan, K.; Mizuguchi, J.; Iwanaga, S.; Nuttall, P.A.; Chan, M.Y.; Kini, R.M. Avathrin: A novel thrombin inhibitor derived from a multicopy precursor in the salivary glands of the ixodid tick, Amblyomma variegatum. FASEB J., 2017, 31(7), 2981-2995.
[http://dx.doi.org/10.1096/fj.201601216R] [PMID: 28363953]

Gardell, S.J.; Ramjit, D.R.; Stabilito, I.I.; Fujita, T.; Lynch, J.J.; Cuca, G.C.; Jain, D.; Wang, S.P.; Tung, J.S.; Mark, G.E. Effective thrombolysis without marked plasminemia after bolus intravenous administration of vampire bat salivary plasminogen activator in rabbits. Circulation, 1991, 84(1), 244-253.
[http://dx.doi.org/10.1161/01.CIR.84.1.244] [PMID: 1905593]

Cappello, M.; Vlasuk, G.P.; Bergum, P.W.; Huang, S.; Hotez, P.J. Ancylostoma caninum anticoagulant peptide: A hookworm-derived inhibitor of human coagulation factor Xa. Proc. Natl. Acad. Sci. USA, 1995, 92(13), 6152-6156.
[http://dx.doi.org/10.1073/pnas.92.13.6152] [PMID: 7597095]

Sawyer, R.T. Thrombolytics and anti-coagulants from leeches. Biotechnology (N. Y.), 1991, 9(6), 513-515, 518.
[PMID: 1367219]

Markwardt, F. Hirudin as an inhibitor of thrombin. Methods Enzymol., 1970, 19, 924-932.
[http://dx.doi.org/10.1016/0076-6879(70)19082-3]

Steiner, V.; Knecht, R.; Börnsen, K.O.; Gassmann, E.; Stone, S.R.; Raschdorf, F.; Schlaeppi, J.M.; Maschler, R. Primary structure and function of novel O-glycosylated hirudins from the leech Hirudinaria manillensis. Biochemistry, 1992, 31(8), 2294-2298.
[http://dx.doi.org/10.1021/bi00123a012] [PMID: 1540584]

Krstenansky, J.L.; Owen, T.J.; Yates, M.T.; Mao, S.J. The Cterminal binding domain of hirullin P18. Antithrombin activity and comparison to hirudin peptides. FEBS Lett., 1990, 262(2), 425-429.
[http://dx.doi.org/10.1016/0014-5793(90)81208-6] [PMID: 2401369]

Strube, K.H.; Kröger, B.; Bialojan, S.; Otte, M.; Dodt, J. Isolation, sequence analysis, and cloning of haemadin. An anticoagulant peptide from the Indian leech. J. Biol. Chem., 1993, 268(12), 8590-8595.
[PMID: 8473305]

Jablonka, W.; Kotsyfakis, M.; Mizurini, D.M.; Monteiro, R.Q.; Lukszo, J.; Drake, S.K.; Ribeiro, J.M.; Andersen, J.F. Identification and mechanistic analysis of a novel tick-derived inhibitor of thrombin. PLoS One, 2015, 10(8)e0133991
[http://dx.doi.org/10.1371/journal.pone.0133991] [PMID: 26244557]

Brahma, R.K.; Blanchet, G.; Kaur, S.; Manjunatha Kini, R.; Doley, R. Expression and characterization of haemathrins, madanin-like thrombin inhibitors, isolated from the salivary gland of tick Haemaphysalis bispinosa (Acari: Ixodidae). Thromb. Res., 2017, 152, 20-29.
[http://dx.doi.org/10.1016/j.thromres.2017.01.012] [PMID: 28213103]

Ibrahim, M.A.; Masoud, H.M.M. Thrombin inhibitor from the salivary gland of the camel tick Hyalomma dromedarii. Exp. Appl. Acarol., 2018, 74(1), 85-97.
[http://dx.doi.org/10.1007/s10493-017-0196-9] [PMID: 29255966]

Bohmann, F.; Mirceska, A.; Pfeilschifter, J.; Lindhoff-Last, E.; Steinmetz, H.; Foerch, C.; Pfeilschifter, W. No influence of dabigatran anticoagulation on hemorrhagic transformation in an experimental model of ischemic stroke. PLoS One, 2012, 7(7)e40804
[http://dx.doi.org/10.1371/journal.pone.0040804] [PMID: 22911709]

Kwon, I.; An, S.; Kim, J.; Yang, S-H.; Yoo, J.; Baek, J-H.; Nam, H.S.; Kim, Y.D.; Lee, H.S.; Choi, H-J.; Heo, J.H. Hemorrhagic transformation after large cerebral infarction in rats pretreated with dabigatran or warfarin. Stroke, 2017, 48(10), 2865-2871.
[http://dx.doi.org/10.1161/STROKEAHA.117.017751] [PMID: 28904233]

Lauer, A.; Cianchetti, F.A.; Van Cott, E.M.; Schlunk, F.; Schulz, E.; Pfeilschifter, W.; Steinmetz, H.; Schaffer, C.B.; Lo, E.H.; Foerch, C. Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage. Circulation, 2011, 124(15), 1654-1662.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.111.035972] [PMID: 21911784]

Choi, H.J.; Kim, N.E.; Kim, J.; An, S.; Yang, S.H.; Ha, J.; Cho, S.; Kwon, I.; Kim, Y.D.; Nam, H.S.; Heo, J.H. Dabigatran reduces endothelial permeability through inhibition of thrombin-induced cytoskeleton reorganization. Thromb. Res., 2018, 167, 165-171.
[http://dx.doi.org/10.1016/j.thromres.2018.04.019] [PMID: 29735342]

Li, C.L.; Dong, M.H.; Ren, Y.J.; Li, L.H. Design, synthesis, biological evaluation and molecular docking of novel dabigatran derivatives as potential thrombin inhibitors. RSC Advances, 2015, 5(30), 23737-23748.
[http://dx.doi.org/10.1039/C5RA01828E]

Li, M.; Ren, Y. Synthesis and Biological Evaluation of Some New 2,5-Substituted 1-Ethyl-1H-benzoimidazole Fluorinated Derivatives as Direct Thrombin Inhibitors. Arch. Pharm. (Weinheim), 2015, 348(5), 353-365.
[http://dx.doi.org/10.1002/ardp.201400463] [PMID: 25824648]

Li, M.L.; Ren, Y.J.; Dong, M.H.; Ren, W.X. Design, synthesis and structural exploration of novel fluorinated dabigatran derivatives as direct thrombin inhibitors. Eur. J. Med. Chem., 2015, 96, 122-138.
[http://dx.doi.org/10.1016/j.ejmech.2015.04.012] [PMID: 25874337]

Chen, H.; Ren, Y. Design, synthesis, and anti-thrombotic evaluation of some novel fluorinated thrombin inhibitor derivatives. Arch. Pharm. (Weinheim), 2015, 348(6), 408-420.
[http://dx.doi.org/10.1002/ardp.201400460] [PMID: 25881141]

Chen, H.F.; Dong, M.H.; Ren, Y.J.; Wang, F. Design, synthesis, biological evaluation and molecular docking studies of dabigatran analogs as potential thrombin inhibitors. J. Indian Chem. Soc., 2016, 13(2), 347-357.
[http://dx.doi.org/10.1007/s13738-015-0743-4]

Dong, M.H.; Chen, H.F.; Ren, Y.J.; Shao, F.M. Molecular modeling studies, synthesis and biological evaluation of dabigatran analogues as thrombin inhibitors. Bioorg. Med. Chem., 2016, 24(2), 73-84.
[http://dx.doi.org/10.1016/j.bmc.2015.11.025] [PMID: 26690913]

Ren, W.; Ren, Y.; Wang, S. Design, synthesis, anticoagulant activity evaluation and molecular docking studies of a class of N-ethyl dabigatran derivatives. Eur. J. Med. Chem., 2016, 120, 148-159.
[http://dx.doi.org/10.1016/j.ejmech.2016.05.020] [PMID: 27187866]

Yang, H.; Liu, Q.; Gao, X.; Ren, Y.; Gao, Y. Novel dabigatran derivatives with a fluorine atom at the C-2 position of the terminal benzene ring: Design, synthesis and anticoagulant activity evaluation. Eur. J. Med. Chem., 2017, 126, 799-809.
[http://dx.doi.org/10.1016/j.ejmech.2016.12.015] [PMID: 27951488]

Yang, X.Z.; Yang, W.H.; Xu, Y.G.; Diao, X.J.; He, G.W.; Gong, G.Q. Synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing a cleavable moiety with anti-platelet activity. Eur. J. Med. Chem., 2012, 57(4), 21-28.
[http://dx.doi.org/10.1016/j.ejmech.2012.09.016] [PMID: 23043765]

Yang, X.Z.; Diao, X.J.; Yang, W.H.; Li, F.; He, G.W.; Gong, G.Q.; Xu, Y.G. Design, synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing methyl ferulate. Bioorg. Med. Chem. Lett., 2013, 23(7), 2089-2092.
[http://dx.doi.org/10.1016/j.bmcl.2013.01.126] [PMID: 23466230]

Wang, S.; Dai, P.; Xu, Y.; Chen, Q.; Zhu, Q.; Gong, G. Design, synthesis, and biological evaluation of dabigatran etexilate mimics, a novel class of thrombin inhibitors. Arch. Pharm. (Weinheim), 2015, 348(8), 595-605.
[http://dx.doi.org/10.1002/ardp.201500101] [PMID: 26120827]

Chen, D.; Wang, S.; Diao, X.; Zhu, Q.; Shen, H.; Han, X.; Wang, Y.; Gong, G.; Xu, Y. Design, synthesis and antithrombotic evaluation of novel dabigatran etexilate analogs, a new series of non-peptides thrombin inhibitors. Bioorg. Med. Chem., 2015, 23(23), 7405-7416.
[http://dx.doi.org/10.1016/j.bmc.2015.10.036] [PMID: 26537784]

Saal, W.V.D.; Kucznierz, R.; Leinert, H.; Engh, R.A. derivatives of 4-amino-pyridine as selective thrombin inhibitors. Bioorg. Med. Chem. Lett., 1997, 7(10), 1283-1288.
[http://dx.doi.org/10.1016/S0960-894X(97)00210-2]

Burgey, C.S.; Robinson, K.A.; Lyle, T.A.; Nantermet, P.G.; Selnick, H.G.; Isaacs, R.C.; Lewis, S.D.; Lucas, B.J.; Krueger, J.A.; Singh, R.; Miller-Stein, C.; White, R.B.; Wong, B.; Lyle, E.A.; Stranieri, M.T.; Cook, J.J.; McMasters, D.R.; Pellicore, J.M.; Pal, S.; Wallace, A.A.; Clayton, F.C.; Bohn, D.; Welsh, D.C.; Lynch, J.J., Jr; Yan, Y.; Chen, Z.; Kuo, L.; Gardell, S.J.; Shafer, J.A.; Vacca, J.P. Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. Implementation of P3 pyridine N-oxides to deliver an orally bioavailable series containing P1 Nbenzylamides. Bioorg. Med. Chem. Lett., 2003, 13(7), 1353-1357.
[http://dx.doi.org/10.1016/S0960-894X(03)00099-4] [PMID: 12657281]

Burgey, C.S.; Robinson, K.A.; Lyle, T.A.; Sanderson, P.E.; Lewis, S.D.; Lucas, B.J.; Krueger, J.A.; Singh, R.; Miller-Stein, C.; White, R.B.; Wong, B.; Lyle, E.A.; Williams, P.D.; Coburn, C.A.; Dorsey, B.D.; Barrow, J.C.; Stranieri, M.T.; Holahan, M.A.; Sitko, G.R.; Cook, J.J.; McMasters, D.R.; McDonough, C.M.; Sanders, W.M.; Wallace, A.A.; Clayton, F.C.; Bohn, D.; Leonard, Y.M.; Detwiler, T.J., Jr; Lynch, J.J., Jr; Yan, Y.; Chen, Z.; Kuo, L.; Gardell, S.J.; Shafer, J.A.; Vacca, J.P. Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridines. J. Med. Chem., 2003, 46(4), 461-473.
[http://dx.doi.org/10.1021/jm020311f] [PMID: 12570369]

Nantermet, P.G.; Burgey, C.S.; Robinson, K.A.; Pellicore, J.M.; Newton, C.L.; Deng, J.Z.; Selnick, H.G.; Lewis, S.D.; Lucas, B.J.; Krueger, J.A.; Miller-Stein, C.; White, R.B.; Wong, B.; McMasters, D.R.; Wallace, A.A.; Lynch, J.J., Jr; Yan, Y.; Chen, Z.; Kuo, L.; Gardell, S.J.; Shafer, J.A.; Vacca, J.P.; Lyle, T.A. P2 pyridine N-oxide thrombin inhibitors: A novel peptidomimetic scaffold. Bioorg. Med. Chem. Lett., 2005, 15(11), 2771-2775.
[http://dx.doi.org/10.1016/j.bmcl.2005.03.110] [PMID: 15911253]

Blomberg, D.; Fex, T.; Xue, Y.; Brickmann, K.; Kihlberg, J. Design, synthesis and biological evaluation of thrombin inhibitors based on a pyridine scaffold. Org. Biomol. Chem., 2007, 5(16), 2599-2605.
[http://dx.doi.org/10.1039/b705344d] [PMID: 18019535]

Lee, L.; Kreutter, K.D.; Pan, W.; Crysler, C.; Spurlino, J.; Player, M.R.; Tomczuk, B.; Lu, T. 2-(2-Chloro-6-fluorophenyl)acetamides as potent thrombin inhibitors. Bioorg. Med. Chem. Lett., 2007, 17(22), 6266-6269.
[http://dx.doi.org/10.1016/j.bmcl.2007.09.013] [PMID: 17889527]

de Candia, M.; Fiorella, F.; Lopopolo, G.; Carotti, A.; Romano, M.R.; Lograno, M.D.; Martel, S.; Carrupt, P.A.; Belviso, B.D.; Caliandro, R.; Altomare, C. Synthesis and biological evaluation of direct thrombin inhibitors bearing 4-(piperidin-1-yl)pyridine at the P1 position with potent anticoagulant activity. J. Med. Chem., 2013, 56(21), 8696-8711.
[http://dx.doi.org/10.1021/jm401169a] [PMID: 24102612]

Aoyama, H.; Ijuin, R.; Kato, J.Y.; Urushiyama, S.; Tetsuhashi, M.; Hashimoto, Y.; Yokomatsu, T. Discovery of non-competitive thrombin inhibitor derived from competitive tryptase inhibitor skeleton: Shift in molecular recognition resulted from skeletal conversion of carboxylate into phosphonate. Bioorg. Med. Chem. Lett., 2015, 25(17), 3676-3680.
[http://dx.doi.org/10.1016/j.bmcl.2015.06.039] [PMID: 26122211]

Sidhu, P.S.; Liang, A.; Mehta, A.Y.; Abdel Aziz, M.H.; Zhou, Q.; Desai, U.R. Rational design of potent, small, synthetic allosteric inhibitors of thrombin. J. Med. Chem., 2011, 54(15), 5522-5531.
[http://dx.doi.org/10.1021/jm2005767] [PMID: 21714536]

Sidhu, P.S.; Abdel Aziz, M.H.; Sarkar, A.; Mehta, A.Y.; Zhou, Q.; Desai, U.R. Designing allosteric regulators of thrombin. Exosite 2 features multiple subsites that can be targeted by sulfated small molecules for inducing inhibition. J. Med. Chem., 2013, 56(12), 5059-5070.
[http://dx.doi.org/10.1021/jm400369q] [PMID: 23718540]

Afosah, D.K.; Verespy, S., III; Al-Horani, R.A.; Boothello, R.S.; Karuturi, R.; Desai, U.R. A small group of sulfated benzofurans induces steady-state submaximal inhibition of thrombin. Bioorg. Med. Chem. Lett., 2018, 28(6), 1101-1105.
[http://dx.doi.org/10.1016/j.bmcl.2018.01.069] [PMID: 29459207]

Salimbeni, A.; Paleari, F.; Canevotti, R.; Criscuoli, M.; Criscuoli, M.; Lippi, A.; Angiolini, M.; Belvisi, L.; Scolastico, C.; Colombo, L. Design and synthesis of conformationally constrained arginal thrombin inhibitors. Bioorg. Med. Chem. Lett., 1997, 7(17), 2205-2210.
[http://dx.doi.org/10.1016/S0960-894X(97)00403-4]

Zega, A.; Mlinsek, G.; Solmajer, T.; Trampus-Bakija, A.; Stegnar, M.; Urleb, U. Thrombin inhibitors built on an azaphenylalanine scaffold. Bioorg. Med. Chem. Lett., 2004, 14(6), 1563-1567.
[http://dx.doi.org/10.1016/j.bmcl.2003.12.083] [PMID: 15006404]

Isaacs, R.C.A.; Newton, C.L.; Cutrona, K.J.; Mercer, S.P.; Payne, L.S.; Stauffer, K.J.; Williams, P.D.; Cook, J.J.; Krueger, J.A.; Lewis, S.D.; Lucas, B.J.; Lyle, E.A.; Lynch, J.J.; McMasters, D.R.; Naylor-Olsen, A.M.; Michener, M.T.; Wallace, A.A. Design, synthesis and SAR of a series of 1,3,5-trisubstituted benzenes as thrombin inhibitors. Bioorg. Med. Chem. Lett., 2011, 21(5), 1536-1540.
[http://dx.doi.org/10.1016/j.bmcl.2010.12.105] [PMID: 21295467]

Blizzard, T.A.; Singh, S.; Patil, B.; Chidurala, N.; Komanduri, V.; Debnath, S.; Belyakov, S.; Crespo, A.; Struck, A.; Kurtz, M.; Wiltsie, J.; Shen, X.; Sonatore, L.; Arocho, M.; Lewis, D.; Ogletree, M.; Biftu, T. Heterocyclic core analogs of a direct thrombin inhibitor. Bioorg. Med. Chem. Lett., 2014, 24(4), 1111-1115.
[http://dx.doi.org/10.1016/j.bmcl.2014.01.002] [PMID: 24461292]

Verespy, S., III; Mehta, A.Y.; Afosah, D.; Al-Horani, R.A.; Desai, U.R. Allosteric partial inhibition of monomeric proteases. sulfated coumarins induce regulation, not just inhibition, of thrombin. Sci. Rep., 2016, 6, 24043.
[http://dx.doi.org/10.1038/srep24043] [PMID: 27053426]

Chen, D.; Shi, J.; Liu, J.; Zhang, X.; Deng, X.; Yang, Y.; Cui, S.; Zhu, Q.; Gong, G.; Xu, Y. Design, synthesis and antithrombotic evaluation of novel non-peptide thrombin inhibitors. Bioorg. Med. Chem., 2017, 25(2), 458-470.
[http://dx.doi.org/10.1016/j.bmc.2016.11.012] [PMID: 27884512]